Statistics for Preclinical characterization of DUOC-01, a cell therapy product derived from banked umbilical cord blood for use as an adjuvant to umbilical cord blood transplantation for treatment of inherited metabolic diseases.

Total visits

views
Preclinical characterization of DUOC-01, a cell therapy product derived from banked umbilical cord blood for use as an adjuvant to umbilical cord blood transplantation for treatment of inherited metabolic diseases. 31

Total visits per month

views
October 2023 1
November 2023 0
December 2023 0
January 2024 0
February 2024 0
March 2024 0
April 2024 0

File Visits

views
p292 Kurtzberg.pdf 16